New Republic Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$203K Sell
2,321
-1,550
-40% -$148K 0.07% 235
2025
Q4
$375K Buy
3,871
+1,755
+83% +$170K 0.1% 183
2025
Q3
$201K Buy
+2,116
New +$195K 0.06% 191
2024
Q1
Sell
-3,134
Closed -$260K 234
2023
Q4
$260K Buy
+3,134
New +$239K 0.19% 126
2023
Q3
Sell
-2,607
Closed -$231K 236
2023
Q2
$231K Buy
+2,607
New +$224K 0.16% 122

Other funds holding MDT

New Republic Capital's MDT Position: Q1 2026 in Review

New Republic Capital reduced its Medtronic (MDT) stake by 40% in Q1 2026, selling an estimated $148K and leaving 2,321 shares worth $203K. The position accounts for 0.07% of the portfolio, ranked #235.

New Republic Capital first reported a position in MDT in Q2 2023 and has held it in 5 quarters since. The position peaked at $375K in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • New Republic Capital held 2,321 shares of Medtronic worth $203K as of Q1 2026.
  • New Republic Capital sold 1,550 Medtronic shares in Q1 2026, an estimated $148K.
  • Medtronic made up 0.07% of New Republic Capital's portfolio in Q1 2026, its #235 holding.
  • New Republic Capital first reported a position in Medtronic in Q2 2023 and has held it in 5 quarters since.
  • New Republic Capital's Medtronic position peaked at $375K in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on New Republic Capital's 13F filing for Q1 2026, filed 1 May 2026.